Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §102 only | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLMES, REX R | 1 | 80.3% | +18.3% |
| COOK, JONATHON | 1 | 81.8% | +16.8% |
| ARIETI, RUTH SOPHIA | 1 | 45.3% | +72.1% |
| OTTON, ALICIA L | 1 | 65.0% | +9.2% |
| SALMON, KATHERINE D | 1 | 42.6% | +38.0% |
| MARTINEZ, TARA L | 1 | 62.7% | +65.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17596758 | DETECTION OF RELB ACTIVATION FOR PREDICTING A PROGNOSTIC IN B-CELL LYMPHOMA | SALMON, KATHERINE D | 23d overdue |
| 17439641 | NEW INHIBITORS OF LRRK2/PP1 INTERACTION | MARTINEZ, TARA L | 55d |
| 18697421 | DEEP BRAIN STIMULATION SYSTEM | HOLMES, REX R | 62d |
| 18564270 | METHODS AND SYSTEMS FOR THREE-DIMENSIONAL IMAGING OF A TRANSPARENT BIOLOGICAL OBJECT IN A BIOLOGICAL SAMPLE BY FULL-FIELD OPTICAL TOMOGRAPHY | COOK, JONATHON | — |
| 18030265 | OLIGOMERIC COMPOUND FOR DYSTROPHIN RESCUE IN DMD PATIENTS THROUGHOUT SKIPPING OF EXON-51 | ARIETI, RUTH SOPHIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17596758 | DETECTION OF RELB ACTIVATION FOR PREDICTING A PROGNOSTIC IN B-CELL LYMPHOMA | SALMON, KATHERINE D | 23d overdue |
| 17439641 | NEW INHIBITORS OF LRRK2/PP1 INTERACTION | MARTINEZ, TARA L | 55d |
| 18697421 | DEEP BRAIN STIMULATION SYSTEM | HOLMES, REX R | 62d |
| 18564270 | METHODS AND SYSTEMS FOR THREE-DIMENSIONAL IMAGING OF A TRANSPARENT BIOLOGICAL OBJECT IN A BIOLOGICAL SAMPLE BY FULL-FIELD OPTICAL TOMOGRAPHY | COOK, JONATHON | — |
| 18030265 | OLIGOMERIC COMPOUND FOR DYSTROPHIN RESCUE IN DMD PATIENTS THROUGHOUT SKIPPING OF EXON-51 | ARIETI, RUTH SOPHIA | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| 2877 | 1 |
| 1635 | 1 |
| 1699 | 1 |
| 1682 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18697421 | DEEP BRAIN STIMULATION SYSTEM | HOLMES, REX R | 3796 | §103§112 | Non-Final OA | 62d | Pending | Mar 29, 2024 |
| 18564270 | METHODS AND SYSTEMS FOR THREE-DIMENSIONAL IMAGING OF A TRANSPARENT BIOLOGICAL OBJECT IN A BIOLOGICAL SAMPLE BY FULL-FIELD OPTICAL TOMOGRAPHY | COOK, JONATHON | 2877 | §102§103 | Non-Final OA | — | Pending | Nov 27, 2023 |
| 18030265 | OLIGOMERIC COMPOUND FOR DYSTROPHIN RESCUE IN DMD PATIENTS THROUGHOUT SKIPPING OF EXON-51 | ARIETI, RUTH SOPHIA | 1635 | §102§103§112Other | Final Rejection | — | Pending | Apr 04, 2023 |
| 17907324 | NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT | OTTON, ALICIA L | 1699 | §102 | Final Rejection | — | Pending | Oct 03, 2022 |
| 17596758 | DETECTION OF RELB ACTIVATION FOR PREDICTING A PROGNOSTIC IN B-CELL LYMPHOMA | SALMON, KATHERINE D | 1682 | §101§112 | Final Rejection | 23d overdue | Pending | Dec 17, 2021 |
| 17439641 | NEW INHIBITORS OF LRRK2/PP1 INTERACTION | MARTINEZ, TARA L | 1654 | §103§112Other | Non-Final OA | 55d | Pending | Sep 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial